Compare Crispr Therapeutics AG (CRSP) vs MINISO Group Holding Ltd (MNSO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crispr Therapeutics AG vs MINISO Group Holding Ltd — how do they compare? Crispr Therapeutics AG trades at $53.9 (market cap $5.23B), while MINISO Group Holding Ltd trades at $11.97 (market cap $3.62B). The key difference: Crispr Therapeutics AG is the larger of the two by market cap, and MINISO Group Holding Ltd pays a 5.53% dividend while Crispr Therapeutics AG pays none. Which is the better fit depends on your goals.
| CRSP | MNSO | |
|---|---|---|
Market Cap | $5.23B | $3.62B |
Sector | Health | Technology |
52-Week High | $76.78 | $26.63 |
52-Week Low | $44.34 | $11.30 |
Enterprise Value | $3.65B | $4.29B |
Dividend Yield | — | 5.53% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Crispr Therapeutics AG
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →About MINISO Group Holding Ltd
MINISO Group Holding Ltd is a global lifestyle product retailer known for its aesthetically pleasing, high-quality, and low-cost goods. The company operates a network of branded stores worldwide, offering a diverse range of merchandise, including household goods, cosmetics, toys, and digital accessories. MINISO's business model emphasizes rapid product iteration, efficient supply chain management, and a joint venture and franchise partner network to facilitate its global expansion.
Read more on MNSO →
